Hans‐Peter Lohrmann

875 total citations
18 papers, 705 citations indexed

About

Hans‐Peter Lohrmann is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Hans‐Peter Lohrmann has authored 18 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Hans‐Peter Lohrmann's work include Neutropenia and Cancer Infections (5 papers), Blood groups and transfusion (5 papers) and Acute Myeloid Leukemia Research (3 papers). Hans‐Peter Lohrmann is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Blood groups and transfusion (5 papers) and Acute Myeloid Leukemia Research (3 papers). Hans‐Peter Lohrmann collaborates with scholars based in Germany, United States and Denmark. Hans‐Peter Lohrmann's co-authors include Robert G. Graw, Ligita Novikovs, W. Schreml, H. Heimpel, Theodor M. Fliedner, Michael Betzler, Tom Kristensen, H. Pflieger, Hans‐Dieter Flad and B. Kubanek and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Annals of Internal Medicine.

In The Last Decade

Hans‐Peter Lohrmann

18 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Peter Lohrmann Germany 10 323 263 145 99 75 18 705
H Tonthat France 9 364 1.1× 211 0.8× 87 0.6× 190 1.9× 69 0.9× 13 766
S Korec United States 9 512 1.6× 229 0.9× 216 1.5× 129 1.3× 86 1.1× 14 862
Shadduck Rk United States 11 261 0.8× 246 0.9× 128 0.9× 106 1.1× 56 0.7× 27 558
W. M. Gallmeier Germany 14 167 0.5× 110 0.4× 152 1.0× 74 0.7× 66 0.9× 52 676
L. L. M. Thomas Netherlands 8 298 0.9× 296 1.1× 190 1.3× 92 0.9× 72 1.0× 17 601
P Miescher Switzerland 14 431 1.3× 147 0.6× 55 0.4× 112 1.1× 55 0.7× 56 1.1k
K A Deubelbeiss Switzerland 7 297 0.9× 374 1.4× 155 1.1× 127 1.3× 225 3.0× 7 935
Z. Mishal France 13 331 1.0× 99 0.4× 74 0.5× 171 1.7× 27 0.4× 23 765
Mammo Amare United States 14 92 0.3× 362 1.4× 216 1.5× 238 2.4× 81 1.1× 28 827
J L Smith United Kingdom 15 298 0.9× 61 0.2× 87 0.6× 116 1.2× 175 2.3× 42 682

Countries citing papers authored by Hans‐Peter Lohrmann

Since Specialization
Citations

This map shows the geographic impact of Hans‐Peter Lohrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Lohrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Lohrmann more than expected).

Fields of papers citing papers by Hans‐Peter Lohrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Peter Lohrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Lohrmann. The network helps show where Hans‐Peter Lohrmann may publish in the future.

Co-authorship network of co-authors of Hans‐Peter Lohrmann

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Peter Lohrmann. A scholar is included among the top collaborators of Hans‐Peter Lohrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Peter Lohrmann. Hans‐Peter Lohrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schreml, W., Michael Betzler, P. Schlag, et al.. (1983). Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)—Six-year evaluation. European Journal of Cancer and Clinical Oncology. 19(5). 607–613. 5 indexed citations
2.
Lohrmann, Hans‐Peter, et al.. (1982). 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.. PubMed. 68(4). 541–7. 9 indexed citations
3.
Schreml, W., et al.. (1982). Attempt at Quantification of the Cytotoxic Drug‐Induced Changes of the Human Bone Marrow Compartments. Scandinavian Journal of Haematology. 28(2). 151–162. 2 indexed citations
4.
Lohrmann, Hans‐Peter & W. Schreml. (1982). Cytotoxic Drugs and the Granulopoietic System. Recent results in cancer research. 81. 1–222. 45 indexed citations
5.
Lohrmann, Hans‐Peter & W. Schreml. (1979). Sensitivity of human granulopoiesis in vitro to adriamycin before and after exposure in vivo.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(2 Pt 1). 527–30. 2 indexed citations
6.
Lohrmann, Hans‐Peter, W. Schreml, Theodor M. Fliedner, & H. Heimpel. (1979). Reaction of human granulopoiesis to high-dose cyclophosphamide therapy. Annals of Hematology. 38(1). 9–16. 30 indexed citations
7.
Schreml, W. & Hans‐Peter Lohrmann. (1979). Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.. PubMed. 39(10). 4195–9. 9 indexed citations
8.
Lohrmann, Hans‐Peter, et al.. (1978). Changes of Granulopoiesis during and after Adjuvant Chemotherapy of Breast Cancer. British Journal of Haematology. 40(3). 369–381. 46 indexed citations
9.
Schmidt, Péter, Hans‐Peter Lohrmann, & H. Heimpel. (1976). Sodium Pertechnetate as a Red Cell Label: In Vitro and In Vivo Studies. British Journal of Haematology. 32(3). 411–420. 6 indexed citations
10.
Lohrmann, Hans‐Peter, Manfred Dietrich, Tom Kristensen, et al.. (1975). Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor. Annals of Hematology. 31(6). 347–354. 28 indexed citations
11.
Lohrmann, Hans‐Peter, Ligita Novikovs, & Robert G. Graw. (1974). CELLULAR INTERACTIONS IN THE PROLIFERATIVE RESPONSE OF HUMAN T AND B LYMPHOCYTES TO PHYTOMITOGENS AND ALLOGENEIC LYMPHOCYTES. The Journal of Experimental Medicine. 139(6). 1553–1567. 158 indexed citations
12.
Lohrmann, Hans‐Peter, et al.. (1974). STIMULATED LYMPHOCYTE CULTURES. The Journal of Experimental Medicine. 139(5). 1037–1048. 36 indexed citations
13.
Lohrmann, Hans‐Peter, et al.. (1974). Platelet Transfusions From HL-A Compatible Unrelated Donors to Alloimmunized Patients. Annals of Internal Medicine. 80(1). 9–14. 93 indexed citations
14.
Lohrmann, Hans‐Peter, Ligita Novikovs, & Robert G. Graw. (1974). Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture. Nature. 250(5462). 144–146. 89 indexed citations
15.
Lohrmann, Hans‐Peter & Ligita Novikovs. (1974). Rosette formation between human T-lymphocytes and unsensitized rhesus monkey erythrocytes. Clinical Immunology and Immunopathology. 3(1). 99–111. 22 indexed citations
16.
Lohrmann, Hans‐Peter. (1974). Mikroangiopathische h�molytische An�mie bei malignen Tumorerkrankungen. Journal of Molecular Medicine. 52(24). 1143–1150. 1 indexed citations
17.
Lohrmann, Hans‐Peter. (1973). Decrease in spleen size in thalassemia major. The Journal of Pediatrics. 82(4). 739–740. 1 indexed citations
18.
Lohrmann, Hans‐Peter, et al.. (1973). Microangiopathic Hemolytic Anemia in Metastatic Carcinoma. Annals of Internal Medicine. 79(3). 368–375. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Tonthat Breakdown of academic impact, for papers by S Korec Breakdown of academic impact, for papers by Shadduck Rk Breakdown of academic impact, for papers by W. M. Gallmeier Breakdown of academic impact, for papers by L. L. M. Thomas Breakdown of academic impact, for papers by P Miescher Breakdown of academic impact, for papers by K A Deubelbeiss Breakdown of academic impact, for papers by Z. Mishal Breakdown of academic impact, for papers by Mammo Amare Breakdown of academic impact, for papers by J L Smith
Rankless by CCL
2026